Atika Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.1M | Sell |
|
|||||
|
2025
Q2 | $9.03M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $8.53M | Buy |
|
|||||
|
2024
Q2 | $5.95M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $12.1M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.27M | Sell |
|
|||||
|
2018
Q1 | $4.88M | Buy |
|
|||||
|
2017
Q4 | $3.18M | Hold |
|
|||||
|
2017
Q3 | $2.94M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.49M | Buy |
|
|||||
|
2016
Q2 | $777K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $2.88M | Buy |
|
|||||
|
2015
Q1 | $574K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.26M | Buy |
|